研究生: |
楊宗霖 Chung-Ling Yang |
---|---|
論文名稱: |
金屬單加氧酵素對於脂肪族C-H鍵的氧化控制:利用含氘與含氟烷烴化合物探討細胞色素P450 BM3催化調控機制之研究 Controlled oxidation of aliphatic C-H bonds in metallo-monooxygenases: Mechanistic insights derived from studies on deuterated and fluorinated hydrocarbons by Cytochrome P450 BM3 |
指導教授: |
俞聖法
Sheng-Fa Yu 李振綱 Cheng-Kang Lee |
口試委員: |
高震宇
none 陳皇州 none 鄒德里 Der-Lii Tzou |
學位類別: |
博士 Doctor |
系所名稱: |
應用科技學院 - 應用科技研究所 Graduate Institute of Applied Science and Technology |
論文出版年: | 2015 |
畢業學年度: | 103 |
語文別: | 中文 |
論文頁數: | 168 |
中文關鍵詞: | 細胞色素P450 BM3 、含氘化合物 、含氟化合物 |
外文關鍵詞: | Cytochrome P450 BM3, fluorinated hydrocarbons |
相關次數: | 點閱:246 下載:2 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
在金屬單加氧酵素,如何去進行在不同基質的C-H鍵氧化機制與酵素內部如何調控位置(區域)特異性或立體選擇性,一直都是讓人非常感興趣的議題。巨大芽胞桿菌(Bacillus megaterium)的細胞色素P450,使用大氣中的氧氣當做氧化劑,氧化C12-C20脂肪酸在ω-1,ω-2或ω-3 C-H鍵的位置。我們利用基因工程進行定點突變細胞色素P450 BM3 (Cytochrome P450 BM-3)的實驗,以結合理想化設計與導引式演化的定點突變法,對於P450 BM3的胺基酸序列進行定點突變,嘗試從靠近活性中心周圍不同的氨基酸位置,篩選出扮演關鍵性角色的位置。
本研究中,除了利用3mt (BM3 A74G F87V L188Q)蛋白來研究其催化中長度的烷烴化合物基質外,亦藉由實驗定點突變Ala328Phe (F328),進行不同碳數直鏈烷類篩選,發現位置選擇性會從2- 3- 和4-醇的催化,轉變為偏向2-號位置為主的選擇性。基質選擇性則由長碳鏈脂肪酸(C12-C22)變成具有丁烷催化能力。Leu188Pro(P450 BM3-FP188)可控制氣體分子進入的位置,能增加丁烷轉換成2-丁醇的催化活性12.5%;當我們引入Ala74Glu(P450 BM3-FPE74),可以大幅提升丁烷轉換成2-丁醇的催化活性提升至將近40%。
最後,一系列氘化和氟化的烷烴基質做為探針,並藉由酵素氧化這些烷烴基質的產物深入了解C-H鍵氧化控制機制。針對各式含氘丁烷與含氟辛烷的單加氧之反應性、羥基化的位置選擇性以及產物的掌性分布做歸納,找出其調控的動態基礎。
The control oxidation of aliphatic C-H bonds in regio- and/or stereo-selective manner by metalloenzymes is of great interest to scientists. Cytochrome P450 BM3 from Bacillus megaterium oxidizes C12-C20 fatty acids at the ω-1, ω-2, or ω-3 position of the CH bond, respectively. We employ the molecular manipulation techniques to overexpress the recombinant BM3 strain and carry out its site-directed mutagenesis study for generation of a variety of strains towards variable selective oxidation with different substrates.
In my study, strain 3mt, A74G F87V L188Q is exploited for the controlled oxidations of medium-chain length alkanes. Single mutation variant, BM3 mutant Ala328Phe (F328), was found with its capability of selective oxidation at the ω1 position of C4-C10 straight-chain alkanes. Interestingly, long-chain fatty acids (C12-C20) are no longer its substrates. It provides a great base to allow us engineering P450 BM3 protein from normal alkanes with medium-chain length such as n-octane gradually to smaller alkane such as n-butane for subsequent studies of controlled oxidation. The introduction of the second mutation, at Leu188Pro (P450 BM3-FP188) can improve the catalytic efficiency from butane to 2-butanol for 12.5%. In addtion, introducinge Ala74Glu (P450 BM3-FPE74) can shrink the substrate pocket down to half of the volume and significantly enhance the catalytic activity of butane to 2- butanol for nearly 40%.
Typically, enzymes invoke host–guest chemistry to sequester the substrates within the protein pockets, exploiting sizes, shapes and specific interactions such as hydrogen-bonding, electrostatic forces and/or van der Waals interactions to control the substrate specificity, regio-specificity and stereo-selectivity. To further investigate this issue, we also develope a series of deuterated and fluorinated aliphatic substrates as probes to gain insights into the controlled C-H oxidations of hydrocarbons facilitated by these enzymes. The effects resulting from the introduction of deuterated butane (isotopomers) and fluorinated octane (Bioisostere) substituents on the mechanistic insights for C-H oxidation and the controls for regio-specificity and stereo-selectivity of the C-H bond activation are discussed.
1. Gregersen, T.,“Rapid method for distinction of Gram-negative from Gram-positive bacteria”, European Journal of Applied Microbiology and Biotechnology, Vol. 5, No. 2, pp. 123-127 (1978)
2. Peters, M. W.; Meinhold, P.; Glieder, A.; Arnold, F. H.,“Regio-and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3”, Journal of the American Chemical Society, Vol. 125, No.44, pp. 13442-13450 (2003)
3. Noble, M.; Miles, C.; Chapman, S.; Lysek, D.; Mackay, A.; Reid, G.; Hanzlik, R.; Munro, A.,“Roles of key active-site residues in flavocytochrome P450 BM3”, Biochem. J, Vol. 339, pp. 371-379 (1999)
4. Urlacher, V. B.; Lutz-Wahl, S.; Schmid, R. D.,“Microbial P450 enzymes in biotechnology”, Applied microbiology and biotechnology, Vol. 64, No. 3, pp. 317-325 (2004)
5. Li, H.; Poulos, T. L.,“The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid”, Nature Structural & Molecular Biology, Vol. 4, No. 2, pp. 140-146 (1997)
6. Sevrioukova, I. F.; Li, H.; Zhang, H.; Peterson, J. A.; Poulos, T. L.,“Structure of a cytochrome P450–redox partner electron-transfer complex”, Proceedings of the National Academy of Sciences, Vol. 96, No. 5, pp. 1863-1868 (1999)
7. Ravichandran, K. G.; Boddupalli, S. S.; Hasermann, C.; Peterson, J. A.; Deisenhofer, J.,“Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's”Science, Vol.261, No. 5122, pp. 731-736 (1993)
8. Haines, D. C.; Tomchick, D. R.; Machius, M.; Peterson, J. A.,“Pivotal role of water in the mechanism of P450BM-3. Biochemistry”, Vol. 40 No. 45, pp. 13456-13465 (2001)
9. Whitehouse, C. J.; Bell, S. G.; Wong, L.-L., “P450BM3 (CYP102A1): connecting the dots”Chem. Soc. Rev., Vol. 41, No. 3, pp.1218-1260 (2012)
10. Ost, T. W.; Miles, C. S.; Murdoch, J.; Cheung, Y.-F.; Reid, G. A.; Chapman, S. K.; Munro, A. W.,“Rational re-design of the substrate binding site of flavocytochrome P450 BM3”,FEBS Letters, Vol. 486, No. 2, pp. 173-177 (2000)
11. Li, H.; Poulos, T.,“Conformational dynamics in cytochrome P450-substrate interactions”, Biochimi , Vol. 78, No. 8, pp. 695-699 (1996)
12. Hegde, A.; Haines, D. C.; Bondlela, M.; Chen, B.; Schaffer, N.; Tomchick, D. R.; Machius, M.; Nguyen, H.; Chowdhary, P. K.; Stewart, L.,“Interactions of substrates at the surface of P450s can greatly enhance substrate potency”, Biochemistry , Vol. 46, No. 49, pp. 14010-14017 (2007)
13. Haines, D. C.; Hegde, A.; Chen, B.; Zhao, W.; Bondlela, M.; Humphreys, J. M.; Mullin, D. A.; Tomchick, D. R.; Machius, M.; Peterson, J. A.,“A single active-site mutation of P450BM-3 dramatically enhances substrate binding and rate of product formation”, Biochemistry, Vol. 50, No. 39, pp. 8333-8341 (2011)
14. Wu, L. L.; Yang, C. L.; Lo, F. C.; Chiang, C. H.; Chang, C. W.; Ng, K. Y.; Chou, H. H.; Hung, H. Y.; Chan, S. I.; Yu, S. S. F.,“Tuning the Regio‐and Stereoselectivity of C-H Activation in n‐Octanes by Cytochrome P450 BM‐3 with Fluorine Substituents: Evidence for Interactions Between a C-F Bond and Aromatic π Systems”, Chemistry-A European Journal, Vol. 17, No. 17, pp. 4774-4787 (2011)
15. Oliver, C. F.; Modi, S.; Sutcliffe, M. J.; Primrose, W. U.; Lian, L.-Y.; Roberts, G. C.,“A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation”, Biochemistry, Vol. 36, No. 7, pp. 1567-1572 (1997)
16. Miura, Y. F., A.J. ,“omega-1, omega-2 and omega-3 hydroxylation of long-chain fatty acids, amides and alcohols by a soluble enzyme system from Bacillus megaterium”, Biochimica et Biophysica Acta, Vol. 388, pp. 305-317 (1975)
17. Shirane, N.; Sui, Z.; Peterson, J. A.; Ortiz de Montellano, P. R.,“Cytochrome P450BM-3 (CYP102): Regiospecificity of oxidation of. omega.-unsaturated fatty acids and mechanism-based inactivation”, Biochemistry , Vol. 32, No. 49, pp. 13732-13741 (1993)
18. Ost, T. W.; Munro, A. W.; Mowat, C. G.; Taylor, P. R.; Pesseguiero, A.; Fulco, A. J.; Cho, A. K.; Cheesman, M. A.; Walkinshaw, M. D.; Chapman, S. K., “Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM”, Biochemistry, Vol. 40, No. 45, pp. 13430-13438 (2011)
19. Cedrone, F.; Ménez, A.; Quéméneur, E.,“Tailoring new enzyme functions by rational redesign”, Current opinion in structural biology, Vol. 10, No. 4, pp. 405-410 (2000)
20. Hult, K.; Berglund, P.,“Enzyme promiscuity: mechanism and applications”TRENDS in Biotechnology, Vol. 25, No. 5, pp. 231-238 (2007)
21. Tracewell, C. A.; Arnold, F. H.,“Directed enzyme evolution: climbing fitness peaks one amino acid at a time”, Current opinion in chemical biology, Vol. 13, No 1, pp. 3-9 (2009)
22. Farinas, E. T.; Schwaneberg, U.; Glieder, A.; Arnold, F. H.,“Directed evolution of a cytochrome P450 monooxygenase for alkane oxidation”, Advanced Synthesis & Catalysis, Vol. 343, No. 6-7, pp. 601-606 (2001)
23. Meinhold, P.; Peters, M. W.; Hartwick, A.; Hernandez, A. R.; Arnold, F. H., “Engineering cytochrome P450 BM3 for terminal alkane hydroxylation”, Advanced Synthesis & Catalysis, Vol. 348, No. 6, pp. 763-772 (2006)
24. Shilov, A. E.; Shul'pin, G. B.,“Activation of C-H bonds by metal complexes”, Chemical reviews, Vol. 97, No. 8, pp. 2879-2932 (1997)
25. 陳耀甥、張鈞崴、楊宗霖、吳麗嵐、江志祥、拉姆、羅文一、陳長謙、俞聖法, 「金屬單加氧酵素內烷烴基質其位置與立體選擇性的活化控制」,化學,第七十一卷,第一期,第1-15頁 (2013)
26. 王永梅、王业柳、田间,「同位素效应简介」,大学化学,第十九卷,第三期,第32-39頁 (2004)
27. Yu, S. S.-F.; Wu, L.-Y.; Chen, K. H.-C.; Luo, W.-I.; Huang, D.-S.; Chan, S. I., “The stereospecific hydroxylation of [2, 2-2H2] butane and chiral dideuteriobutanes by the particulate methane monooxygenase from Methylococcus capsulatus (Bath)”, Journal of Biological Chemistry, Vol. 278, No. 42, pp. 40658-40669 (2003)
28. 洪惠瑩,「Cytochrome P450 BM-3 作為烷烴化合物的催化試劑」,碩士論文,國立成功大學,台南 (2007)
29. Omura, T.; Sanders, E.; Estabrook, R.; Cooper, D.; Rosenthal, O.,“Isolation from adrenal cortex of a nonheme iron protein and a flavoprotein functional as a reduced triphosphopyridine nucleotide-cytochrome P-450 reductase”, Archives of Biochemistry and Biophysics, Vol. 117, No. 3, pp. 660-673 (1966)
30. Seifert, A.; Vomund, S.; Grohmann, K.; Kriening, S.; Urlacher, V. B.; Laschat, S.; Pleiss, J.,“Rational Design of a Minimal and Highly Enriched CYP102A1 Mutant Library with Improved Regio‐, Stereo‐and Chemoselectivity”, Chembiochem, Vol. 10, No. 5, pp. 853-861 (2009)
31. Appel, D.; Lutz-Wahl, S.; Fischer, P.; Schwaneberg, U.; Schmid, R. D.,“A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes”, Journal of biotechnology, Vol. 88, No. 2, pp. 167-171 (2001)
32. Fasan, R.; Meharenna, Y. T.; Snow, C. D.; Poulos, T. L.; Arnold, F. H., “Evolutionary history of a specialized P450 propane monooxygenase”Journal of molecular biology, Vol. 383, No. 5, pp. 1069-1080 (2008)
33. Chiang, C. H.; Ramu, R.; Tu, Y. J.; Yang, C. L.; Ng, K. Y.; Luo, W. I.; Chen, C. H.; Lu, Y. Y.; Liu, C. L.; Yu, S. S. F.,“Regioselective Hydroxylation of C12–C15 Fatty Acids with Fluorinated Substituents by Cytochrome P450 BM3”, Chemistry-A European Journal, Vol. 19, No. 41, pp. 13680-13691 (2013)
34. Cryle, M. J.; Matovic, N. J.; De Voss, J. J.,“Weak Hydrogen Bridges: A Systematic Theoretical Study on the Nature and Strength of C-H…F-C Interactions”, Tetrahedron Letters, Vol. 48, No. 1, pp. 133-136 (2007)
35. Cryle, M. J.; De Voss, J. J.,“Facile determination of the absolute stereochemistry of hydroxy fatty acids by GC: application to the analysis of fatty acid oxidation by a P450BM3 mutant”, Tetrahedron: Asymmetry, Vol. 18, No. 4, pp. 547-551 (2007)
36. Truan, G.; Komandla, M. R.; Falck, J. R.; Peterson, J. A.,“P450BM-3: absolute configuration of the primary metabolites of palmitic acid”, Archives of biochemistry and biophysics, Vol. 366, No. 2, pp. 192-198 (1999)
37. Chen, Y.-S.; Luo, W.-I.; Yang, C.-L.; Tu, Y.-J.; Chang, C.-W.; Chiang, C.-H.; Chang, C.-Y.; Chan, S. I.; Yu, S. S.-F.,“Controlled oxidation of aliphatic C-H bonds in metallo-monooxygenases: Mechanistic insights derived from studies on deuterated and fluorinated hydrocarbons”, Journal of inorganic biochemistry, Vol. 134, pp. 118-133 (2014)
38. Alonso, H.; Roujeinikova, A.,“Characterization and two-dimensional crystallization of membrane component AlkB of the medium-chain alkane hydroxylase system from Pseudomonas putida GPo1”, Applied and environmental microbiology, Vol. 78, No. 22, pp. 7946-7953 (2012)
39. Chen, P. P.-Y.; Chan, S. I.,“Theoretical modeling of the hydroxylation of methane as mediated by the particulate methane monooxygenase”, Journal of inorganic biochemistry, Vol. 100, No. 4, pp. 801-809 (2006)
40. Li, H.; Poulos, T. L., “Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450 BM-3”, Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, Vol. 1441, No. 2, pp. 141-149 (1999)
41. O'Hagan, D., “Understanding organofluorine chemistry. An introduction to the C–F bond”, Chemical Society Reviews, Vol. 37, No. 2, pp. 308-319 (2008)
42. Hyla‐Kryspin, I.; Haufe, G.; Grimme, S., “Weak Hydrogen Bridges: A Systematic Theoretical Study on the Nature and Strength of C-H⋅⋅⋅ F-C Interactions”, Chemistry-A European Journal, Vol. 10, No. 14, pp. 3411-3422 (2004)
43. Rybalova, T.; Bagryanskaya, I. Y., “C-F... π, F... H, and F... F intermolecular interactions and F-aggregation: Role in crystal engineering of fluoroorganic compounds”, Journal of Structural Chemistry, Vol. 50, No.4, pp. 741-753 (2009)
44. Müller, K.; Faeh, C.; Diederich, F.,“Fluorine in pharmaceuticals: looking beyond intuition”, Science, Vol. 317 No. 5846, pp. 1881-1886 (2007)
45. Mecinovic, J.; Snyder, P. W.; Mirica, K. A.; Bai, S.; Mack, E. T.; Kwant, R. L.; Moustakas, D. T.; Héroux, A.; Whitesides, G. M.,“Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the “hydrophobic wall” of carbonic anhydrase”, Journal of the American Chemical Society, Vol. 133, NO. 35, pp. 14017-14026 (2011)
46. Dalvi, V. H.; Rossky, P. J.,“Molecular origins of fluorocarbon hydrophobicity”, Proceedings of the National Academy of Sciences, Vol. 107, No. 31, pp. 13603-13607 (2010)
47. Smart, B. E.,“Fluorine substituent effects (on bioactivity)”, Journal of Fluorine Chemistry, Vol. 109, No. 1, pp. 3-11 (2011)
48. Pongdee, R.; Liu, H.-w.,“Elucidation of enzyme mechanisms using fluorinated substrate analogues”, Bioorganic chemistry, Vol. 32, No. 5, pp. 393-437 (2004)
49. Ng, K. Y.; Tu, L. C.; Wang, Y. S.; Chan, S. I.; Yu, S. S. F.,“Probing the hydrophobic pocket of the active site in the particulate methane monooxygenase (pMMO) from Methylococcus capsulatus (Bath) by variable stereoselective alkane hydroxylation and olefin epoxidation”, ChemBioChem, Vol. 9, No. 7, pp. 1116-1123 (2008)
50. Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V.,“Fluorine in medicinal chemistry”, Chemical Society Reviews, Vol. 37, No. 2, pp. 320-330 (2008)
51. Böhm, H. J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst‐Sander, U.; Stahl, M.,“Fluorine in medicinal chemistry”, ChemBioChem, Vol. 5, No. 5, pp. 637-643 (2004)
52. Li, Q. S.; Schwaneberg, U.; Fischer, P.; Schmid, R. D.,“Directed Evolution of the Fatty‐Acid Hydroxylase P450 BM‐3 into an Indole‐Hydroxylating Catalyst”, Chemistry-A European Journal, Vol. 6, No. 9, pp. 1531-1536 (2000)
53. Zilly, F. E.; Acevedo, J. P.; Augustyniak, W.; Deege, A.; Häusig, U. W.; Reetz, M. T.,“Tuning a P450 enzyme for methane oxidation”, Angewandte Chemie, Vol. 123 No. 12, pp. 2772-2776 (2011)
54. Li, C.; Shaik, S.,“How do perfluorinated alkanoic acids elicit cytochrome P450 to catalyze methane hydroxylation? An MD and QM/MM study”, RSC advances, Vol. 3, No. 9, pp. 2995-3005 (2013)